Dartmouth and Aeras join forces to conduct study of new tuberculosis vaccine

(The Geisel School of Medicine at Dartmouth) Dartmouth's Geisel School of Medicine and Aeras, a global nonprofit biotech, announced a collaboration to jointly conduct a trial of a new vaccine against tuberculosis, one of the world's deadliest diseases. The vaccine, known as DAR-901, is related to the vaccine SRL-172, previously shown by Dartmouth investigators to decrease the risk of tuberculosis in a trial known as the DarDar Trial.